Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?
    Navneet S. Majhail, MD and Alan E. Lichtin, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 259-262;

    The only way is to stop the suspected drug and see if the thrombocytopenia resolves. But how to avoid stopping needed drugs that are not a problem?

  • You have access
    How to use nesiritide in treating decompensated heart failure
    Roger M. Mills, MD and Robert E. Hobbs, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 252-256;

    Nesiritide, a recombinant formulation of BNP, is the first new parenteral drug in more than a decade to be approved for treating heart failure.

  • You have access
    How to assess and counsel the older driver
    Barbara J. Messinger-Rapport, MD, PhD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 184-192;

    Suggesting that a patient stop driving is never easy, yet taking no action may have deadly consequences.

  • You have access
    The B-type natriuretic peptide assay: A rapid test for heart failure
    W. Frank Peacock, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 243-251;

    This 15-minute test is highly sensitive and fairly specific and is useful in evaluating suspected heart failure in outpatients and in emergency care.

  • What is hemochromatosis?
    You have access
    What is hemochromatosis?
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 238;
  • You have access
    Hereditary hemochromatosis: A common, often unrecognized, genetic disease
    Geraldine M. McCarthy, MD, Conor J. McCarthy, MD, Dermot Kenny, MD, John Crowe, MD, PhD and Stephen Eustace, MB
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 224-237;

    Although hereditary hemochromatosis is one of the most common genetic diseases affecting people of northern European descent, it is underdiagnosed.

  • What is the best diagnostic approach when pheochromocytoma is suspected?
    You have access
    What is the best diagnostic approach when pheochromocytoma is suspected?
    Emmanuel L. Bravo, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 257-258;

    First prove there is catecholamine overproduction, then obtain an MRI to locate the tumor.

  • You have access
    Oncologic emergencies for the internist
    William S. Krimsky, MD, Robert J. Behrens, MD and Gary J. Kerkvliet, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 209-222;

    The complications the general internist is most likely to see and can least afford to miss.

  • You have access
    Chronic tension-type headache: Advice for the viselike-headache patient
    Glen D. Solomon, MD
    Cleveland Clinic Journal of Medicine February 2002, 69 (2) 167-172;

    About 3% of people complain of daily viselike headaches without associated symptoms. Therapy consists of tricyclic antidepressants, biofeedback, and stress management, although solid data are lacking.

  • You have access
    Halting the progression of heart failure: Finding the optimal combination therapy
    Jan N. Basile, MD
    Cleveland Clinic Journal of Medicine February 2002, 69 (2) 104-112;

    Recommendations on how to find the optimal combination of agents that can slow the progression of heart failure while minimizing side effects.

Pages

  • Previous
  • Next
  • 1
  • …
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397
  • 398
  • 399
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire